Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 5,973,296 | reported | 28 Jun 2021 | tx 7+7,692,298−23,450,637 |
| MBX Biosciences, Inc. | 3,114,486 | reported | 16 Sept 2024 | tx 5+3,614,486−37,442,694 |
| Korro Bio, Inc. | 1,090,793 | reported | 22 Apr 2024 | tx 1+17,857 |
| Bright Health Group Inc. | 674,554 | reported | 02 Oct 2025 | tx 10+561,451−1,163,133 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Oct 2025 | EXERCISE | Bright Health Group Inc. | 189,195 | 0.01 USD | |
| 02 Oct 2025 | SALE | Bright Health Group Inc. | 280 | 6.75 USD | |
| 02 Oct 2025 | EXERCISE | Bright Health Group Inc. | 186,128 | 0.01 USD | |
| 02 Oct 2025 | TAX_WITHHOLDING | Bright Health Group Inc. | 276 | 6.75 USD | |
| 02 Oct 2025 | OTHER | Bright Health Group Inc. | 674,554 | — | |
| 02 Oct 2025 | EXERCISE | Bright Health Group Inc. | 189,195 | 0.00 USD | deriv |
| 02 Oct 2025 | GRANT_AWARD | Bright Health Group Inc. | 186,128 | — | deriv |
| 02 Oct 2025 | EXERCISE | Bright Health Group Inc. | 186,128 | 0.00 USD | deriv |
| 02 Oct 2025 | OTHER | Bright Health Group Inc. | 75,000 | — | deriv |
| 02 Oct 2025 | OTHER | Bright Health Group Inc. | 37,700 | — | deriv |
| 16 Sept 2024 | PURCHASE | MBX Biosciences, Inc. | 500,000 | 16.00 USD | |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 2,091,383 | — | |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 1,023,103 | — | |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 12,299,854 | — | deriv |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 25,142,840 | — | deriv |
| 22 Apr 2024 | PURCHASE | Korro Bio, Inc. | 17,857 | 56.00 USD | first after silence |
| 28 Jun 2021 | CONVERSION | Monte Rosa Therapeutics, Inc. | 669,002 | — | |
| 28 Jun 2021 | CONVERSION | Monte Rosa Therapeutics, Inc. | 3,257,328 | — | |
| 28 Jun 2021 | CONVERSION | Monte Rosa Therapeutics, Inc. | 2,715,968 | — | |
| 28 Jun 2021 | PURCHASE | Monte Rosa Therapeutics, Inc. | 1,050,000 | 19.00 USD | |
| 28 Jun 2021 | CONVERSION | Monte Rosa Therapeutics, Inc. | 9,588,725 | — | deriv |
| 28 Jun 2021 | CONVERSION | Monte Rosa Therapeutics, Inc. | 2,361,912 | — | deriv |
| 28 Jun 2021 | CONVERSION | Monte Rosa Therapeutics, Inc. | 11,500,000 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 22 Apr 2024.